- Who We Are
- Our Focus
- Clinical Trials
Addressing unmet needs in medical dermatology
Dermatological diseases affect tens of millions of people worldwide each year, impacting their quality of life, and physical, functional and emotional well-being.
Despite this, and despite progress in the development of biologic therapies to treat dermatological diseases, the vast majority of dermatology patients continue to be treated by older therapies that offer inadequate efficacy, do not target specific disease mediators, or that carry with them substantial safety and tolerability issues. Dermatologists and patients badly need innovative topical treatments that directly target molecular mediators of disease with high local skin efficacy, low systemic safety risks, the ability to use chronically, and a good high risk/benefit ratio.